Increased recognition of HFM and the identification of further families and PCFT mutations will provide opportunities to define possible genotype–phenotype correlations and further explore the basis of the marked phenotypic variability that is characteristic of this condition. The gene discussed is SLC46A1; the disease is craniofacial microsomia.